Mersana Therapeutics Inc (MRSN)
Mersana Therapeutics Inc
(MRSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,998 | 75,186 | 174,561 | 186,283 | 128,732 |
| Marketable Securities | 103,744 | 107,960 | 34,523 | 54,703 | 157,856 |
| Receivables | 1,570 | N/A | N/A | N/A | N/A |
| TOTAL | $168,963 | $187,538 | $214,057 | $249,738 | $297,087 |
| Non-Current Assets | |||||
| PPE Net | 3,005 | 3,408 | 3,831 | 4,265 | 4,266 |
| Other Non-Current Assets | 7,160 | 7,427 | 8,172 | 8,901 | 9,647 |
| TOTAL | $10,165 | $10,835 | $12,003 | $13,166 | $13,913 |
| Total Assets | $179,128 | $198,373 | $226,060 | $262,904 | $311,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,333 | 5,208 | 2,083 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,013 | 3,086 | 7,319 | 12,946 | 16,918 |
| Accrued Expenses | 17,782 | 15,856 | 21,898 | 29,321 | 33,468 |
| Other current liabilities | 57 | 91 | 938 | 937 | 1,009 |
| TOTAL | $62,184 | $53,406 | $63,637 | $67,933 | $74,920 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,049 | 20,098 | 23,148 | 25,155 | 25,080 |
| Deferred Revenues | 29,345 | 25,618 | 28,147 | 21,592 | 20,500 |
| Other Non-Current Liabilities | 3,897 | 4,862 | 5,204 | 6,117 | 7,003 |
| TOTAL | $108,517 | $116,982 | $125,519 | $142,776 | $146,280 |
| Total Liabilities | $170,701 | $170,388 | $189,156 | $210,709 | $221,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,907 | 4,894 | 4,852 | 4,823 | 4,820 |
| Common Shares | 12 | 12 | 12 | 12 | 12 |
| Retained earnings | -869,935 | -845,667 | -826,361 | -806,817 | -765,161 |
| Other shareholders' equity | -71 | -90 | 11 | 1 | -49 |
| TOTAL | $8,427 | $27,985 | $36,904 | $52,195 | $89,800 |
| Total Liabilities And Equity | $179,128 | $198,373 | $226,060 | $262,904 | $311,000 |